Overview
Neuca is a listed company and a leader in pharmaceutical wholesale in Poland, supporting independent pharmacies. It also develops a patient-focused business under the Świat Zdrowia brand, covering medical facilities, imaging diagnostics centers and digital tools. The group also expands clinical trials activities and sustainability initiatives.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 709.00
- High
- PLN 710.00
- Low
- PLN 702.00
- Volume
- 262
- Avg. vol.
- 1.83K
- Market cap
- PLN 3.28B
- P/E ratio
- 16.68
- EPS
- PLN 42.38
- Shares outstanding
- 4.64M
- 52-week
- PLN 690.00 – 725.00
- Dividend yield
- 2.52%
- Dividend
- PLN 17.80
- Ex dividend date
- Jun 29, 2026
- ISIN
- PLTRFRM00018
- Exchange
- GPW Main Market
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 964.59m | USD 17.79m | USD 11.02m |
| Q1 2026 | USD 960.81m | USD 26.12m | USD 18.46m |
| Q4 2025 | USD 884.19m | USD 13.60m | USD 6.81m |
| Q3 2025 | USD 876.15m | USD 19.72m | USD 15.13m |
Results for Q3 2026:Nov 19, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Was a VAT taxpayer from 1994-04-01 to 2024-10-31. Removed from VAT register
Reason for removal: Art. 96 ust. 7ba (deregistration of a VAT group member upon VAT group registration)
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Nov 20, 2023 | Commercial Companies Code notice |
Public aid
5 public aid cases recorded, with a total value of $1,461,886.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Aug 2, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | Instytut Nauk Społeczno-Ekonomicznych sp. z o.o. + limited partnership | |
| May 24, 2021 | Aid for research and development projects: experimental development | –– | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| May 24, 2021 | Aid for research and development projects: industrial research | –– | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
2 projects recorded: 1 from FE lists ($1,411,569) and 1 Commission grant (FTS) ($0).
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-04-01 | Opracowanie innowacji procesowej w postaci systemu przeznaczonego do procesów kontroli jakości związanych z dystrybucją farmaceutyków i innych wyrobów medycznych | $1.4M$1,411,569 | Program Operacyjny Inteligentny Rozwój | |
| 2018-04-01 | 777773 - C-voucher - circularize value chains across european regional innovation strategies | $0$0 | 1.1.31 - Horizon 2020 |
Tenders
2595 tenders recorded as contractor: 548 national ($23,047,007) and 2047 EU ($6,782,923,208).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 16, 2026 | Dostawa leków i wybranych wyrobów medycznych - pak. 1, 2, 3. | –– | Wojewódzki Zespół Lecznictwa Psychiatrycznego w Olsztynie | |
| Oct 16, 2026 | Dostawy leków i wyrobów medycznych - znak sprawy: Z/47/PN/26 | –– | Regionalny Szpital Specjalistyczny Im. Dr. Władysława Biegańskiego | |
| Oct 16, 2026 | Zakup produktów leczniczych, materiałów opatrunkowych, rękawic, wyrobów medycznych, mleka i innych według załączonych 180 pakietów na okres 24 miesięcy | –– | Specjalistyczny Szpital Im. Dra Alfreda Sokołowskiego |
Public sector contracts
Neuca is the contractor in 1943 public sector contracts, worth PLN 85.72m in total. They were signed with 265 public buyers. The largest number (7) were signed with Uniwersyteckie Centrum Kliniczne.
| Public buyer | Value | |
|---|---|---|
| Wielkopolskie Centrum Neuropsychiatryczne Im. Oskara Bielawskiego w Kościanie | PLN 9.68 | |
| Samodzielny Publiczny Kliniczny Szpital Okulistyczny w Warszawie | PLN 2,310 | |
| Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych I Administracji Centrum Rehabilitacji w Górznie | PLN 660.91 | |
| Regionalny Szpital Specjalistyczny Im. Dr. Władysława Biegańskiego | PLN 3,073,900 | |
| Wielkopolskie Centrum Neuropsychiatryczne Im. Oskara Bielawskiego w Kościanie | PLN 712.95 |
Public procurement disputes (KIO)
Neuca has been a party to 3 cases before the National Appeal Chamber (since 2018). It filed 1 appeal (1 dismissed). In 2 cases it joined the proceedings as a participant.
National Health Fund (NFZ) contracts
Neuca has been an NFZ healthcare provider since 2023. In 2026 it is performing 16 contracts with a total value of USD 0.00. All its contracts were worth USD 0.00 in total.
NFZ contract value by year (USD)
| Type of care | NFZ branch | Contracts | Value in 2026 |
|---|---|---|---|
| Zaopatrzenie w wyroby medyczne | dolnośląskie | 1 | USD 0.00 |
| Zaopatrzenie w wyroby medyczne | kujawsko-pomorskie | 1 | USD 0.00 |
| Zaopatrzenie w wyroby medyczne | lubelskie | 1 | USD 0.00 |
| Zaopatrzenie w wyroby medyczne | lubuskie | 1 | USD 0.00 |
| Zaopatrzenie w wyroby medyczne | łódzkie | 1 | USD 0.00 |
Trademarks
Neuca holds 8 active trademarks registered with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2004.
| Mark | Protected until | |
|---|---|---|
| APTELINE ŚWIAT ZDROWIA | Jul 24, 2034 | |
| STACJA FARMACJA PODCAST | Sep 21, 2031 | |
| HeyDoc BLIŻEJ ZDROWIA | Oct 19, 2030 | |
| SUPLINDEX | Jul 29, 2029 | |
| NEUCA Zdrowe Innowacje(word) | Feb 12, 2028 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, are authorized to submit declarations of will and represent the company.
Supervisory board
Beneficial owners
No beneficial owners recorded for the company Neuca.
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Świat ZdrowiaS.A. | – | 100% | ||
Neuca Inwestycjesp. z o.o. | 113,731,320.91 USD | 100% | ||
Neuca Clinical Trials Investmentssp. z o.o. | 23,273,906.00 USD | 100% |
Capital group
| Name | Ownership |
|---|---|
| 100% | |
Neuca Clinical Trials Investment Sp. z o.o  | 100% |
| 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Roche Polskasp. z o.o. | $799,694,562.77 | roche.pl | ||
| Bayersp. z o.o. | $624,313,880.67 | talent.bayer.com | ||
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| HurtapS.A. | $480,276,955.20 | hurtap.com.pl | ||
| Sanofisp. z o.o. | $384,123,246.36 | sanofi.com | ||
| USP Zdrowiesp. z o.o. | $377,149,656.94 | uspzdrowie.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-10 | Share capital change (4,626,044.00 PLN → 4,642,802.00 PLN) | |
| 2026-04-16 | Share capital change (4,554,344.00 PLN → 4,626,044.00 PLN) | |
| 2025-08-08 | Share capital change (4,552,744.00 PLN → 4,554,344.00 PLN) | |
| 2025-06-10 | Share capital change (4,549,444.00 PLN → 4,552,744.00 PLN) | |
| 2025-04-15 | Share capital change (4,542,304.00 PLN → 4,549,444.00 PLN) |
FAQ
Last updated: 2026-09-10